microRNA information: hsa-miR-1266-5p
| Section | ID | link |
|---|---|---|
| Mature name: | hsa-miR-1266-5p | miRbase |
| Accession: | MIMAT0005920 | miRbase |
| Precursor name: | hsa-mir-1266 | miRbase |
| Precursor accession: | MI0006403 | miRbase |
| Symbol: | MIR1266 | HGNC |
| RefSeq ID: | NR_031670 | GenBank |
| Sequence: | CCUCAGGGCUGUAGAACAGGGCU |
Reported expression in cancers: hsa-miR-1266-5p
| miRNA | cancer | regulation | reporting | PUBMED | method |
|---|
Reported cancer pathway affected by hsa-miR-1266-5p
| miRNA | cancer | pathway | reporting | PUBMED | functional study |
|---|---|---|---|---|---|
| hsa-miR-1266-5p | gastric cancer | cell cycle pathway | "miR 1207 5p and miR 1266 suppress gastric cancer g ......" | 24481448 | Luciferase; Flow cytometry; Transwell assay |
Reported cancer prognosis affected by hsa-miR-1266-5p
| miRNA | cancer | prognosis | reporting | PUBMED | functional study |
|---|---|---|---|---|---|
| hsa-miR-1266-5p | breast cancer | metastasis; recurrence; drug resistance; staging | "Association of miR 1266 with recurrence/metastasis ......" | 25640367 |
Reported gene related to hsa-miR-1266-5p
| miRNA | cancer | gene | reporting | PUBMED |
|---|---|---|---|---|
| hsa-miR-1266-5p | breast cancer | ESR1 | "Association of miR 1266 with recurrence/metastasis ......" | 25640367 |
Expression profile in cancer corhorts:
Putative target regulations
| miRNA | Gene | Cancer | Interaction | Correlation beta |
|---|---|---|---|---|
hsa-miR-1266-5p | WIPF1 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.31; TCGA BRCA -0.053; TCGA CESC -0.127; TCGA COAD -0.241; TCGA ESCA -0.188; TCGA HNSC -0.06; TCGA LUAD -0.162; TCGA LUSC -0.076; TCGA PRAD -0.102; TCGA THCA -0.179; TCGA STAD -0.176; TCGA UCEC -0.168 |
hsa-miR-1266-5p | ABL2 | 10 cancers: BLCA; COAD; ESCA; HNSC; LGG; LUAD; LUSC; OV; PAAD; STAD | MirTarget | TCGA BLCA -0.093; TCGA COAD -0.125; TCGA ESCA -0.119; TCGA HNSC -0.136; TCGA LGG -0.133; TCGA LUAD -0.061; TCGA LUSC -0.061; TCGA OV -0.057; TCGA PAAD -0.11; TCGA STAD -0.082 |
hsa-miR-1266-5p | NDST1 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LUSC; OV; PAAD; STAD; UCEC | MirTarget | TCGA BLCA -0.112; TCGA BRCA -0.066; TCGA CESC -0.189; TCGA COAD -0.091; TCGA ESCA -0.136; TCGA HNSC -0.167; TCGA KIRP -0.072; TCGA LUSC -0.077; TCGA OV -0.11; TCGA PAAD -0.124; TCGA STAD -0.137; TCGA UCEC -0.091 |
hsa-miR-1266-5p | EGR2 | 11 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRP; LIHC; LUAD; LUSC; STAD; UCEC | MirTarget | TCGA BLCA -0.278; TCGA BRCA -0.173; TCGA CESC -0.181; TCGA COAD -0.394; TCGA ESCA -0.364; TCGA KIRP -0.229; TCGA LIHC -0.245; TCGA LUAD -0.212; TCGA LUSC -0.135; TCGA STAD -0.132; TCGA UCEC -0.253 |
hsa-miR-1266-5p | KIAA1644 | 16 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.622; TCGA CESC -0.224; TCGA COAD -0.585; TCGA ESCA -0.48; TCGA HNSC -0.527; TCGA KIRP -0.297; TCGA LGG -0.351; TCGA LIHC -0.314; TCGA LUAD -0.177; TCGA LUSC -0.201; TCGA OV -0.315; TCGA PAAD -0.194; TCGA PRAD -0.254; TCGA THCA -0.305; TCGA STAD -0.665; TCGA UCEC -0.525 |
hsa-miR-1266-5p | RIC3 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; LGG; OV; PAAD; PRAD; STAD; UCEC | MirTarget | TCGA BLCA -0.283; TCGA BRCA -0.268; TCGA CESC -0.314; TCGA COAD -0.699; TCGA ESCA -0.419; TCGA KIRC -0.388; TCGA LGG -0.138; TCGA OV -0.256; TCGA PAAD -0.438; TCGA PRAD -0.178; TCGA STAD -0.695; TCGA UCEC -0.668 |
hsa-miR-1266-5p | PI16 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; KIRP; OV; PAAD; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.435; TCGA BRCA -0.451; TCGA CESC -0.184; TCGA COAD -0.695; TCGA ESCA -0.221; TCGA KIRC -0.631; TCGA KIRP -0.349; TCGA OV -0.288; TCGA PAAD -0.456; TCGA PRAD -0.421; TCGA THCA -0.484; TCGA STAD -0.803; TCGA UCEC -0.606 |
hsa-miR-1266-5p | BVES | 10 cancers: BLCA; COAD; ESCA; HNSC; OV; PAAD; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.27; TCGA COAD -0.487; TCGA ESCA -0.413; TCGA HNSC -0.123; TCGA OV -0.21; TCGA PAAD -0.165; TCGA PRAD -0.186; TCGA THCA -0.234; TCGA STAD -0.684; TCGA UCEC -0.411 |
hsa-miR-1266-5p | SV2B | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; LUAD; OV; PAAD; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.252; TCGA BRCA -0.177; TCGA CESC -0.277; TCGA COAD -0.451; TCGA ESCA -0.338; TCGA LUAD -0.232; TCGA OV -0.263; TCGA PAAD -0.255; TCGA PRAD -0.222; TCGA THCA -0.407; TCGA STAD -0.445; TCGA UCEC -0.433 |
hsa-miR-1266-5p | FMOD | 9 cancers: BLCA; BRCA; COAD; HNSC; LUAD; LUSC; OV; STAD; UCEC | MirTarget | TCGA BLCA -0.346; TCGA BRCA -0.141; TCGA COAD -0.207; TCGA HNSC -0.079; TCGA LUAD -0.12; TCGA LUSC -0.118; TCGA OV -0.288; TCGA STAD -0.151; TCGA UCEC -0.232 |
hsa-miR-1266-5p | LYNX1 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUSC; PRAD; STAD; UCEC | MirTarget | TCGA BLCA -0.267; TCGA BRCA -0.277; TCGA CESC -0.194; TCGA COAD -0.417; TCGA ESCA -0.404; TCGA HNSC -0.312; TCGA KIRC -0.175; TCGA KIRP -0.24; TCGA LIHC -0.121; TCGA LUSC -0.276; TCGA PRAD -0.169; TCGA STAD -0.519; TCGA UCEC -0.357 |
hsa-miR-1266-5p | TEF | 10 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRP; LGG; LUSC; STAD; UCEC | MirTarget | TCGA BLCA -0.092; TCGA BRCA -0.059; TCGA CESC -0.209; TCGA COAD -0.124; TCGA ESCA -0.139; TCGA KIRP -0.177; TCGA LGG -0.12; TCGA LUSC -0.062; TCGA STAD -0.262; TCGA UCEC -0.224 |
hsa-miR-1266-5p | CDHR1 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; THCA; STAD | MirTarget | TCGA BLCA -0.163; TCGA BRCA -0.342; TCGA CESC -0.566; TCGA COAD -0.516; TCGA ESCA -0.875; TCGA HNSC -0.367; TCGA LGG -0.477; TCGA LIHC -0.244; TCGA LUAD -0.28; TCGA LUSC -0.356; TCGA PAAD -0.271; TCGA PRAD -0.134; TCGA THCA -0.281; TCGA STAD -0.466 |
hsa-miR-1266-5p | KCNJ5 | 9 cancers: BLCA; BRCA; CESC; COAD; ESCA; OV; PAAD; STAD; UCEC | MirTarget | TCGA BLCA -0.214; TCGA BRCA -0.08; TCGA CESC -0.205; TCGA COAD -0.325; TCGA ESCA -0.176; TCGA OV -0.151; TCGA PAAD -0.259; TCGA STAD -0.217; TCGA UCEC -0.23 |
hsa-miR-1266-5p | PDE2A | 16 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; OV; PAAD; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.232; TCGA BRCA -0.23; TCGA CESC -0.144; TCGA COAD -0.447; TCGA HNSC -0.152; TCGA KIRC -0.113; TCGA KIRP -0.287; TCGA LGG -0.334; TCGA LIHC -0.389; TCGA LUAD -0.108; TCGA OV -0.245; TCGA PAAD -0.298; TCGA PRAD -0.188; TCGA THCA -0.249; TCGA STAD -0.464; TCGA UCEC -0.527 |
hsa-miR-1266-5p | ANXA6 | 11 cancers: BLCA; COAD; HNSC; LIHC; LUAD; OV; PAAD; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.37; TCGA COAD -0.297; TCGA HNSC -0.063; TCGA LIHC -0.199; TCGA LUAD -0.104; TCGA OV -0.238; TCGA PAAD -0.182; TCGA PRAD -0.159; TCGA THCA -0.123; TCGA STAD -0.288; TCGA UCEC -0.151 |
hsa-miR-1266-5p | CLIP3 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRP; LGG; LUAD; OV; PAAD; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.268; TCGA BRCA -0.08; TCGA CESC -0.127; TCGA COAD -0.487; TCGA ESCA -0.258; TCGA KIRP -0.249; TCGA LGG -0.107; TCGA LUAD -0.174; TCGA OV -0.325; TCGA PAAD -0.298; TCGA PRAD -0.263; TCGA THCA -0.242; TCGA STAD -0.573; TCGA UCEC -0.408 |
hsa-miR-1266-5p | MCC | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LIHC; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.176; TCGA BRCA -0.096; TCGA CESC -0.439; TCGA COAD -0.369; TCGA ESCA -0.5; TCGA HNSC -0.118; TCGA KIRC -0.103; TCGA LIHC -0.136; TCGA LUSC -0.291; TCGA OV -0.228; TCGA PAAD -0.127; TCGA PRAD -0.132; TCGA THCA -0.148; TCGA STAD -0.397; TCGA UCEC -0.215 |
hsa-miR-1266-5p | SEMA3G | 9 cancers: BLCA; BRCA; COAD; KIRC; KIRP; PAAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.086; TCGA BRCA -0.23; TCGA COAD -0.354; TCGA KIRC -0.269; TCGA KIRP -0.261; TCGA PAAD -0.247; TCGA THCA -0.186; TCGA STAD -0.219; TCGA UCEC -0.146 |
hsa-miR-1266-5p | DPYSL3 | 12 cancers: BLCA; BRCA; COAD; ESCA; KIRP; LGG; LUAD; PAAD; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.407; TCGA BRCA -0.094; TCGA COAD -0.544; TCGA ESCA -0.4; TCGA KIRP -0.24; TCGA LGG -0.15; TCGA LUAD -0.257; TCGA PAAD -0.153; TCGA PRAD -0.205; TCGA THCA -0.18; TCGA STAD -0.584; TCGA UCEC -0.32 |
hsa-miR-1266-5p | ATP10D | 9 cancers: BLCA; CESC; ESCA; HNSC; LUAD; LUSC; OV; STAD; UCEC | MirTarget | TCGA BLCA -0.212; TCGA CESC -0.242; TCGA ESCA -0.285; TCGA HNSC -0.249; TCGA LUAD -0.079; TCGA LUSC -0.162; TCGA OV -0.155; TCGA STAD -0.122; TCGA UCEC -0.238 |
hsa-miR-1266-5p | BCL2L2 | 9 cancers: BLCA; CESC; ESCA; HNSC; KIRC; KIRP; LUSC; PRAD; UCEC | MirTarget | TCGA BLCA -0.128; TCGA CESC -0.12; TCGA ESCA -0.122; TCGA HNSC -0.071; TCGA KIRC -0.137; TCGA KIRP -0.121; TCGA LUSC -0.086; TCGA PRAD -0.054; TCGA UCEC -0.192 |
hsa-miR-1266-5p | TMOD1 | 13 cancers: BLCA; BRCA; COAD; ESCA; KIRC; LGG; LIHC; LUAD; PAAD; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.169; TCGA BRCA -0.139; TCGA COAD -0.191; TCGA ESCA -0.2; TCGA KIRC -0.145; TCGA LGG -0.089; TCGA LIHC -0.227; TCGA LUAD -0.074; TCGA PAAD -0.275; TCGA PRAD -0.115; TCGA THCA -0.186; TCGA STAD -0.388; TCGA UCEC -0.166 |
hsa-miR-1266-5p | CHST3 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC | MirTarget | TCGA BLCA -0.169; TCGA BRCA -0.221; TCGA CESC -0.109; TCGA COAD -0.389; TCGA ESCA -0.339; TCGA HNSC -0.121; TCGA LGG -0.141; TCGA LUAD -0.144; TCGA LUSC -0.142; TCGA OV -0.201; TCGA PAAD -0.134; TCGA PRAD -0.122; TCGA STAD -0.288; TCGA UCEC -0.094 |
hsa-miR-1266-5p | ADAMTS6 | 10 cancers: BLCA; COAD; HNSC; KIRP; LGG; LUAD; LUSC; OV; THCA; STAD | MirTarget | TCGA BLCA -0.284; TCGA COAD -0.217; TCGA HNSC -0.227; TCGA KIRP -0.164; TCGA LGG -0.242; TCGA LUAD -0.182; TCGA LUSC -0.13; TCGA OV -0.189; TCGA THCA -0.322; TCGA STAD -0.21 |
hsa-miR-1266-5p | ANK2 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; KIRP; LUAD; OV; PAAD; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.36; TCGA BRCA -0.142; TCGA CESC -0.21; TCGA COAD -0.637; TCGA ESCA -0.211; TCGA KIRC -0.173; TCGA KIRP -0.299; TCGA LUAD -0.201; TCGA OV -0.245; TCGA PAAD -0.368; TCGA PRAD -0.149; TCGA THCA -0.286; TCGA STAD -0.719; TCGA UCEC -0.227 |
hsa-miR-1266-5p | PRIMA1 | 11 cancers: BLCA; CESC; COAD; ESCA; LIHC; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | MirTarget | TCGA BLCA -0.247; TCGA CESC -0.451; TCGA COAD -0.905; TCGA ESCA -0.528; TCGA LIHC -0.197; TCGA LUAD -0.332; TCGA LUSC -0.283; TCGA PAAD -0.28; TCGA PRAD -0.275; TCGA STAD -1.011; TCGA UCEC -0.449 |
hsa-miR-1266-5p | DPT | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; LIHC; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.727; TCGA BRCA -0.279; TCGA CESC -0.284; TCGA COAD -0.698; TCGA ESCA -0.376; TCGA LIHC -0.392; TCGA LUAD -0.202; TCGA LUSC -0.206; TCGA OV -0.332; TCGA PAAD -0.311; TCGA PRAD -0.409; TCGA THCA -0.582; TCGA STAD -0.616; TCGA UCEC -0.64 |
hsa-miR-1266-5p | RASGRF2 | 11 cancers: BLCA; COAD; HNSC; KIRP; LUAD; LUSC; OV; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.16; TCGA COAD -0.151; TCGA HNSC -0.082; TCGA KIRP -0.286; TCGA LUAD -0.19; TCGA LUSC -0.151; TCGA OV -0.206; TCGA PRAD -0.172; TCGA THCA -0.229; TCGA STAD -0.193; TCGA UCEC -0.245 |
hsa-miR-1266-5p | COL4A2 | 11 cancers: BLCA; BRCA; COAD; HNSC; LUAD; LUSC; OV; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.19; TCGA BRCA -0.105; TCGA COAD -0.22; TCGA HNSC -0.159; TCGA LUAD -0.102; TCGA LUSC -0.072; TCGA OV -0.118; TCGA PRAD -0.119; TCGA THCA -0.207; TCGA STAD -0.207; TCGA UCEC -0.132 |
hsa-miR-1266-5p | KCNA6 | 9 cancers: BLCA; BRCA; ESCA; HNSC; KIRC; LUAD; OV; STAD; UCEC | MirTarget | TCGA BLCA -0.184; TCGA BRCA -0.173; TCGA ESCA -0.304; TCGA HNSC -0.12; TCGA KIRC -0.116; TCGA LUAD -0.201; TCGA OV -0.609; TCGA STAD -0.586; TCGA UCEC -0.393 |
hsa-miR-1266-5p | CYP26B1 | 11 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUSC; OV; THCA; UCEC | MirTarget | TCGA BLCA -0.233; TCGA BRCA -0.299; TCGA CESC -0.125; TCGA COAD -0.2; TCGA ESCA -0.215; TCGA HNSC -0.382; TCGA KIRC -0.143; TCGA LUSC -0.086; TCGA OV -0.448; TCGA THCA -0.261; TCGA UCEC -0.385 |
hsa-miR-1266-5p | MTSS1L | 11 cancers: BRCA; ESCA; KIRC; KIRP; LGG; LIHC; LUAD; PAAD; THCA; STAD; UCEC | MirTarget | TCGA BRCA -0.069; TCGA ESCA -0.194; TCGA KIRC -0.112; TCGA KIRP -0.178; TCGA LGG -0.139; TCGA LIHC -0.062; TCGA LUAD -0.067; TCGA PAAD -0.102; TCGA THCA -0.066; TCGA STAD -0.225; TCGA UCEC -0.053 |
hsa-miR-1266-5p | SRRM3 | 13 cancers: BRCA; CESC; COAD; ESCA; LGG; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BRCA -0.16; TCGA CESC -0.349; TCGA COAD -0.225; TCGA ESCA -0.402; TCGA LGG -0.434; TCGA LUAD -0.234; TCGA LUSC -0.284; TCGA OV -0.272; TCGA PAAD -0.328; TCGA PRAD -0.136; TCGA THCA -0.12; TCGA STAD -0.155; TCGA UCEC -0.156 |
hsa-miR-1266-5p | MME | 11 cancers: BRCA; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; OV; PRAD; UCEC | MirTarget | TCGA BRCA -0.246; TCGA HNSC -0.202; TCGA KIRC -0.398; TCGA KIRP -0.32; TCGA LGG -0.375; TCGA LIHC -1.059; TCGA LUAD -0.2; TCGA LUSC -0.207; TCGA OV -0.361; TCGA PRAD -0.24; TCGA UCEC -0.262 |
hsa-miR-1266-5p | PPP1R3F | 12 cancers: BRCA; CESC; COAD; ESCA; KIRC; LGG; LIHC; LUAD; PAAD; PRAD; STAD; UCEC | MirTarget | TCGA BRCA -0.119; TCGA CESC -0.148; TCGA COAD -0.241; TCGA ESCA -0.17; TCGA KIRC -0.071; TCGA LGG -0.058; TCGA LIHC -0.16; TCGA LUAD -0.094; TCGA PAAD -0.264; TCGA PRAD -0.134; TCGA STAD -0.267; TCGA UCEC -0.213 |
hsa-miR-1266-5p | ASTN1 | 13 cancers: BRCA; COAD; ESCA; KIRC; KIRP; LGG; LIHC; OV; PAAD; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BRCA -0.251; TCGA COAD -0.669; TCGA ESCA -0.47; TCGA KIRC -0.405; TCGA KIRP -0.498; TCGA LGG -0.14; TCGA LIHC -0.246; TCGA OV -0.368; TCGA PAAD -0.508; TCGA PRAD -0.241; TCGA THCA -0.359; TCGA STAD -0.937; TCGA UCEC -0.485 |
hsa-miR-1266-5p | ZNF853 | 11 cancers: BRCA; COAD; ESCA; KIRC; LGG; LUAD; OV; PAAD; PRAD; STAD; UCEC | MirTarget | TCGA BRCA -0.061; TCGA COAD -0.48; TCGA ESCA -0.217; TCGA KIRC -0.194; TCGA LGG -0.075; TCGA LUAD -0.092; TCGA OV -0.249; TCGA PAAD -0.2; TCGA PRAD -0.124; TCGA STAD -0.469; TCGA UCEC -0.2 |
hsa-miR-1266-5p | ADD2 | 10 cancers: BRCA; CESC; COAD; ESCA; LGG; LUAD; PAAD; THCA; STAD; UCEC | MirTarget | TCGA BRCA -0.116; TCGA CESC -0.157; TCGA COAD -0.584; TCGA ESCA -0.615; TCGA LGG -0.246; TCGA LUAD -0.178; TCGA PAAD -0.413; TCGA THCA -0.26; TCGA STAD -0.51; TCGA UCEC -0.233 |
hsa-miR-1266-5p | LHX6 | 10 cancers: BRCA; CESC; COAD; LIHC; LUAD; OV; PAAD; THCA; STAD; UCEC | MirTarget | TCGA BRCA -0.111; TCGA CESC -0.156; TCGA COAD -0.211; TCGA LIHC -0.105; TCGA LUAD -0.144; TCGA OV -0.229; TCGA PAAD -0.208; TCGA THCA -0.195; TCGA STAD -0.192; TCGA UCEC -0.252 |
hsa-miR-1266-5p | NRIP2 | 10 cancers: BRCA; COAD; KIRP; LUAD; OV; PAAD; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BRCA -0.186; TCGA COAD -0.229; TCGA KIRP -0.213; TCGA LUAD -0.059; TCGA OV -0.161; TCGA PAAD -0.196; TCGA PRAD -0.083; TCGA THCA -0.119; TCGA STAD -0.253; TCGA UCEC -0.183 |
hsa-miR-1266-5p | SLC35B4 | 9 cancers: CESC; KIRC; KIRP; LIHC; OV; PAAD; THCA; STAD; UCEC | MirTarget | TCGA CESC -0.057; TCGA KIRC -0.073; TCGA KIRP -0.108; TCGA LIHC -0.052; TCGA OV -0.111; TCGA PAAD -0.077; TCGA THCA -0.051; TCGA STAD -0.107; TCGA UCEC -0.14 |
hsa-miR-1266-5p | ABHD6 | 9 cancers: CESC; KIRC; LGG; LIHC; LUSC; OV; PRAD; THCA; UCEC | MirTarget | TCGA CESC -0.079; TCGA KIRC -0.107; TCGA LGG -0.167; TCGA LIHC -0.279; TCGA LUSC -0.074; TCGA OV -0.085; TCGA PRAD -0.085; TCGA THCA -0.07; TCGA UCEC -0.077 |
hsa-miR-1266-5p | ZMIZ1 | 9 cancers: CESC; COAD; ESCA; LGG; LUSC; OV; PRAD; STAD; UCEC | MirTarget | TCGA CESC -0.105; TCGA COAD -0.081; TCGA ESCA -0.068; TCGA LGG -0.185; TCGA LUSC -0.085; TCGA OV -0.135; TCGA PRAD -0.064; TCGA STAD -0.161; TCGA UCEC -0.167 |
Enriched cancer pathways of putative targets